BSE filing, NSE: GROVY. Summary written from the filing by ALFA Finder's alert engine.
Grovy India Ltd: key numbers
- Share price
- ₹65.00
- Market cap
- ₹86.69 Cr
- Revenue (annual)
- ₹33.20 Cr
- Net profit (annual)
- ₹2.90 Cr
- P/E (TTM)
- 16.2×Sector 33.7×
- Promoter holding
- 65.13%-7.87% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Grovy India Ltd
All →Grovy India Legal & Regulatory
ITAT Delhi deleted a ₹1 Crore Section 68 addition for Grovy India for AY 2020-21. The Tribunal partly allowed the company's appeal, reducing tax demand.
- Value
- ₹1.00 Cr
Grovy India Investor Presentation: Key Takeaways
H1 FY27 revenue ₹54.76 Cr (+129.84% YoY), H1 PAT ₹3.92 Cr, EPS ₹2.67. Borrowings cut 89.62% to ₹2.59 Cr. ROCE 7.10%.
Grovy India Q2 FY27 Results: Net Profit ₹2 Cr, Up 400.0% YoY
Grovy India Ltd reported revenue from operations of ₹26.9 Cr (+79.3% YoY) and net profit of ₹2 Cr (+400.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2 Cr · +400.0% YoY
Grovy India Board Meeting Date
Grovy India Limited scheduled a board meeting for October 26, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Grovy India Other Announcement
Grovy India Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, in accordance with SEBI regulations.
Grovy India Other Announcement
Grovy India Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This is a routine periodic disclosure of shareholding data.
Other other announcement announcements
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.